Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 4, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details specific transfers of Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- October 2, 2006: Transfer of 2,100 Ordinary Shares.
- October 3, 2006: Transfer of 110,426 Ordinary Shares.
Three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) are noted as having an interest in the shares held in the GSK Trust in the same capacity as other employees.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the aforementioned share transactions in accordance with Disclosure Rule 3.1.4R(1)(b).
Key Facts for Investor Verification
- Verify the total number of shares transferred from the GSK Trust to the Employee Share Option Plan 1991 during the reporting period (112,526 shares total).
- Confirm the specific dates of the transactions (October 2 and October 3, 2006).
- Note that the GSK Trust is a discretionary trust for current and former employees, creating a potential interest for the named directors.